UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Why was Il-yang out from innovative pharmaceutical firms list?
Il-yang Pharmaceutical, HanAll Biopharma, and Bioneer have failed to renew ...
by So Jae-hyeon
|
2018-06-20 17:13
라인
GC, Yuhan to cooperate for drug development
GC CEO Huh Eun-chul (left) and Yuhan Corp. CEO Lee Jung-hee hold the MOU af...
by Lee Han-soo
|
2018-06-19 16:07
라인
Safety of heat-not-burn tobacco still controversial
The fight between the Ministry of Food and Drug Safety and the tobacco indu...
by Lee Hye-seon
|
2018-06-19 15:41
라인
Dong-A ST’s toenail fungal treatment leads local market
Dong-A ST said Jublia, the company’s toenail fungal treatment, has become a...
by Lee Han-soo
|
2018-06-19 15:07
라인
EU approves Daewoong’s Nabota plant
Daewoong Pharmaceutical said Tuesday that it has received good manufacturin...
by Lee Han-soo
|
2018-06-19 11:43
라인
‘Medytox botulinum toxin worth 600 billion won in China’
Neuronox, the botulinum toxin developed by Medytox that is seeking China’s ...
by Nam Doo-hyun
|
2018-06-19 09:26
라인
Companies enter pharma biz through equity investment, acquisition
More Korean companies are entering the pharmaceutical market either by equi...
by So Jae-hyeon
|
2018-06-18 16:13
라인
BMS Korea presents trial results for Baraclude
Bristol-Myers Squibb Korea said Monday that it has presented study findings...
by Marian Chu
|
2018-06-18 11:46
라인
Will SGLT-2 inhibitors win more antidiabetic prescriptions?
The pharmaceutical industry is actively discussing merits of sodium-glucose...
by Nam Doo-hyun
|
2018-06-15 11:58
라인
Huons to export BTX to Brazil, Iran
Huons said Thursday that it has signed a contract to export Hutox, its botu...
by Lee Han-soo
|
2018-06-14 16:15
라인
Highlights of US cancer meet: immunotherapy, gastrointestinal cancer
Immunotherapies and gastrointestinal cancer drew the most attention during ...
by Nam Doo-hyun
|
2018-06-14 15:51
라인
Samsung Bioepis to promote rheumatism treatments in Europe
Samsung Biopepis is stepping up efforts to enlarge its share in the Europea...
by So Jae-hyeon
|
2018-06-14 14:59
라인
S. Korea’s national squad vaccinated for 2018 World Cup
Sanofi Pasteur Korea said Monday it administered three types of vaccines to...
by Marian Chu
|
2018-06-12 17:28
라인
Hanmi unveils two clinical trial results at EU conference
Hanmi Pharmaceutical said Tuesday that it has presented clinical trial resu...
by Lee Han-soo
|
2018-06-12 15:36
라인
What if South Korea supplies vaccines for North?
Under the reconciliatory atmosphere between South Korea and North Korea, a ...
by So Jae-hyeon
|
2018-06-12 15:36
라인
Obesity drugs marked poor sales in Q1
Most obesity treatments suffered sales declines in the first quarter, and p...
by So Jae-hyeon
|
2018-06-12 15:32
라인
UCB Korea withdraws epilepsy drug Vimpat
UCB Korea has taken Vimpat (ingredient: lacosamide) off the Korean market a...
by Marian Chu
|
2018-06-12 11:22
라인
Dongkook, Chong Kun Dang most popular in functional foods
Dongkook Pharmaceutical, Chong Kung Dang Healthcare, and Sanofi-Aventis Kor...
by Nam Doo-hyun
|
2018-06-12 11:19
라인
Janssen Korea gets expanded indication for Zytiga
Janssen Korea said Tuesday it got the Ministry of Food and Drug Safety’s ap...
by Marian Chu
|
2018-06-12 11:01
라인
Will Yervoy+Cemiplimab combo fight non-small cell lung cancer?
A global phase-2 clinical trial will soon take place in Korea to check if a...
by Lee Hye-seon
|
2018-06-11 15:11
-
이전
81
82
83
84
85
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top